Twist Bioscience Corporation

Supplier Profile

Overview

Updated August 2024

Incorporated Country

Subsidiaries

124

Tier 1 Connections

$8.83M

Prime Awards

Supplier Summary

Ark.ai conducted a vendor and supply chain analysis of Twist Bioscience Corporation, examining their subcontractors, subsidiaries, list of suppliers, manufacturers, shippers, and other members of their supply chain – as well as their key government customers and contracts. The resulting vendor analysis and supplier profile includes a supply chain analysis, an evaluation of key subcontractors and prime contractors, and an assessment of their compliance risk and supply chain risk.

The analysis of Twist Bioscience Corporation resulted in the following statistics. Twist Bioscience Corporation has a Count of Subsidiaries of 14 and a Count of Tier 1 Connections of 124. Their government contract revenue over the past three years is $8.83M.

Information about Twist Bioscience Corporation's federal profile including a list of suppliers, list of primes, and list of customers are included in the following tables.

Learn More

Top Funding Offices

Agency	Sub-Agency	Funding Office	Prime Contract Awards
Department of Health and Human Services	National Institutes of Health	NATIONAL INSTITUTES OF HEALTH NHLBI	$6,800,000
Department of Defense (DoD)	Defense Advanced Research Projects Agency	DEF ADVANCED RESEARCH PROJECTS AGCY	$4,536,221
Department of Health and Human Services	Centers for Disease Control and Prevention	CDC OFFICE OF ACQUISITION SERVICES	$1,469,433
Department of Health and Human Services	National Institutes of Health	NATIONAL INSTITUTES OF HEALTH NIAID	$299,492
Department of Health and Human Services	National Institutes of Health	NATIONAL INSTITUTES OF HEALTH NIA	$103,451

Top Subsidiaries

Company Name	Country Code	Count of Contracts	Total Award Amount
Twist Bioscience Germany GmbH	DE	0	$0
TWIST	FR	0	$0
Genome Compiler Israel Ltd.	IL	0	$0
Twist Bioscience Worldwide	KY	0	$0
Twist Bioscience Netherlands BV	NL	0	$0

Recent Tier 1 Suppliers

Name	Relationship	Country	Start Date
Bruker Cellular Analysis, Inc.	SUPPLIER	US	4/17/23
Bruker Cellular Analysis, Inc.	SUPPLIER	US	3/16/23
Applied Stemcell, Inc.	SUPPLIER	US	12/10/21
INTEGRA Microfluidics Corporation	SUPPLIER	US	12/2/20
Genapsys, Inc.	SUPPLIER	US	12/2/20

Top Contracts

Contract ID	Entity Name	Dollars Awarded	Funding Office
75N92022C00004	Twist Bioscience Corporation	$6,800,000	NATIONAL INSTITUTES OF HEALTH NHLBI
75D30121P10611	Twist Bioscience Corporation	$540,143	CDC OFFICE OF ACQUISITION SERVICES
75D30121P10368	Twist Bioscience Corporation	$263,625	CDC OFFICE OF ACQUISITION SERVICES
75D30120P09907	Twist Bioscience Corporation	$220,066	CDC OFFICE OF ACQUISITION SERVICES
75D30124P19390	Twist Bioscience Corporation	$157,390	CDC OFFICE OF ACQUISITION SERVICES

List of UEIs for Twist Bioscience Corporation

CMN5DM38JLN1, QPJ3MS46MQP1

ABOUT SUPPLIER ANALYSIS

Ark.ai provides definitive, consolidated analyses of every vendor, subcontractor, supplier, grant awardee, non-profit, and investment organization in the national security and defense sectors. Organization profile pages provide a real-time view of the companies that impact critical government programs.

Learn More

EXPLORE ADDITIONAL ANALYSES

ABOUT ARK.AI

The Ark is the only software platform purpose-built for Defense Acquisition that leverages authoritative commercial data and AI-enabled Applications designed to solve Acquisition challenges. With the Ark, analysts and decision-makers gain the ability to manage Acquisition programs proactively, allowing them to unwind the legacy complexity and effectively field modern warfighting systems that compete with China.

The Leading Defense Acquisition Software.

OUR APPLICATIONS

AI-enabled Applications within The Ark reflect standard workflows across the Defense Acquisition Process. From Science & Technology to Modernization, these Applications allow for the execution of rapid, efficient, data-informed decisions, standardized reporting, and efficient workflow management. The Ark enables your team to transform Defense Acquisition into a strategic advantage.